Fundraising Fox

Vilya

<UNKNOWN>, US · 4 known investors

vilyatx.com ↗

Vilya designs novel macrocycles using AI and computational biology to create medicines that don't exist in nature. The company develops therapeutics for disease by generating entirely new molecules with the targeting precision of antibodies but in pill form.

AI & Machine LearningBiotechDeep Techin /vilyatx

Founders & leadership

DB
David BakerScientific Founder
CH
Cyrus Harmon, PhDCEO and President
PS
Patrick Salveson, PhDCo-Founder, CTO
AM
Adam Moyer, PhDCo-Founder, VP of Molecular Design
DB
David Baker, PhDNobel laureate, Co-Founder, Director, IPD UW, Prof. Biochemistry
GB
Gaurav Bhardwaj, PhDCo-Founder, UW, Asst. Prof. Medicinal Chemistry
LS
Lance Stewart, PhD, MBACo-Founder, CSO & COO, IPD
NH
Nao Hiranuma, PhDCo-Founder, Director of Machine Learning

Investors · 4

ARCH Venture PartnersChicago
Madrona Venture GroupSeattle
Menlo VenturesMenlo Park
NVenturesreportedSingapore

In the news